BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2796018)

  • 1. Changes in brown adipose tissue metabolism following intraventricular vasoactive intestinal peptide and other gastrointestinal peptides in rats.
    Shido O; Yoneda Y; Nagasaka T
    Jpn J Physiol; 1989; 39(3):359-69. PubMed ID: 2796018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of brown adipose tissue metabolism following intraventricular bombesin in rats.
    Shido O; Noda Y; Nagasaka T
    Jpn J Physiol; 1987; 37(4):573-83. PubMed ID: 3430867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intraventricular administration of vasoactive intestinal polypeptide on body temperature in the rat.
    Itoh S; Hirota R
    Jpn J Physiol; 1982; 32(4):677-81. PubMed ID: 6129338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vasoactive intestinal peptide, somatostatin, neurotensin, cholecystokinin octapeptide, and secretin on intestinal absorption of amino acid in rat.
    Chen YF; Feng ZT; Wen SH; Lu GJ
    Dig Dis Sci; 1987 Oct; 32(10):1125-9. PubMed ID: 2888609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vasoactive intestinal polypeptide (VIP) on lower esophageal sphincter in awake baboons: comparison with glucagon and secretin.
    Siegel SR; Brown FC; Castell DO; Johnson LF; Said SI
    Dig Dis Sci; 1979 May; 24(5):345-9. PubMed ID: 110570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glucagon, secretin, and vasoactive intestinal polypeptide on gastric somatostatin and gastrin release from isolated perfused rat stomach.
    Chiba T; Taminato T; Kadowaki S; Abe H; Chihara K; Seino Y; Matsukura S; Fujita T
    Gastroenterology; 1980 Jul; 79(1):67-71. PubMed ID: 6103859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the effects of vasoactive intestinal peptide (VIP) on blood flow through and salivation of the dog salivary gland in comparison with those of secretin, glucagon and acetylcholine.
    Shimizu T; Taira N
    Br J Pharmacol; 1979 Apr; 65(4):683-7. PubMed ID: 435691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide.
    Tanimoto K; Tamminga CA; Chase TN; Nilaver G
    Endocrinology; 1987 Jul; 121(1):127-32. PubMed ID: 3297634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cholecystokinin octapeptide and vasoactive intestinal polypeptide on adrenocortical secretion in the rat.
    Itoh S; Hirota R; Katsuura G
    Jpn J Physiol; 1982; 32(4):553-60. PubMed ID: 6294390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretin and vasoactive intestinal peptide acutely increase tyrosine 3-monooxygenase in the rat superior cervical ganglion.
    Ip NY; Ho CK; Zigmond RE
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7566-9. PubMed ID: 6130526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin downregulates receptors for vasoactive intestinal peptide and secretin in rat pancreatic acini.
    Katsushima S; Adachi H; Honda T; Sato S; Kusui T; Onishi S; Aoki E; Noguchi M; Konishi J
    Am J Physiol; 1990 Mar; 258(3 Pt 1):G395-403. PubMed ID: 2156442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of retinal adenylate cyclase by vasoactive intestinal peptide (VIP).
    Longshore MA; Makman MH
    Eur J Pharmacol; 1981 Mar; 70(2):237-40. PubMed ID: 7262187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute stimulation of ganglionic tyrosine hydroxylase activity by secretin, VIP and PHI.
    Ip NY; Baldwin C; Zigmond RE
    Peptides; 1984; 5(2):309-12. PubMed ID: 6147816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of 3 particulate proteins in rat pancreatic acini in response to vasoactive intestinal peptide (VIP), secretin and cholecystokinin (CCK-8).
    Vandermeers A; Vandermeers-Piret MC; Rathe J; Dehaye JP; Winand J; Christophe J
    Peptides; 1984; 5(2):359-65. PubMed ID: 6089135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vasoactive intestinal peptide, secretin, and related peptides on rat colonic transport and adenylate cyclase activity.
    Waldman DB; Gardner JD; Zfass AM; Makhlouf GM
    Gastroenterology; 1977 Sep; 73(3):518-23. PubMed ID: 892349
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of gastrointestinal and related hormones on glycogenolysis and gluconeogenesis in cultured liver cells.
    Matsumura M; Akiyoshi H; Fujii S
    J Biochem; 1977 Oct; 82(4):1073-6. PubMed ID: 924981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of somatostatin on gastrointestinal hormone-induced glycogenolysis and gluconeogenesis in cultured liver cells.
    Matsumura M; Akiyoshi H; Saito S
    Gastroenterol Jpn; 1980; 15(5):439-43. PubMed ID: 6108278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postreceptor modulation of action of VIP and secretin on pancreatic enzyme secretion by secretagogues that mobilize cellular calcium.
    Collen MJ; Sutliff VE; Pan GZ; Gardner JD
    Am J Physiol; 1982 Apr; 242(4):G423-8. PubMed ID: 6175231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of [4Cl-D-Phe6,Leu17]VIP on the inhibition of pulsatile LH release by VIP and related peptides in the ovariectomized rat.
    Weick RF; Stobie KM; Noh KA
    Neuroendocrinology; 1992 Nov; 56(5):646-52. PubMed ID: 1488097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of secretin, glucagon and vasoactive intestinal peptide on the hormone-sensitive rat cardiac adenylate cyclase [proceedings].
    Chatelain P; Deschodt-Lanckman M; De Neef P; Christophe J; Robberecht P
    Arch Int Physiol Biochim; 1979 Oct; 87(4):783-4. PubMed ID: 93901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.